159 related articles for article (PubMed ID: 12173567)
1. Africa access: moving fast, outcome uncertain.
James JS
AIDS Treat News; 2001 Feb; (360):4-8. PubMed ID: 12173567
[TBL] [Abstract][Full Text] [Related]
2. Africa, access, and patents: moving fast.
James JS
AIDS Treat News; 1999 Jul; (No 322):5-8. PubMed ID: 11366567
[TBL] [Abstract][Full Text] [Related]
3. Global patent police block cost-reduction efforts.
Kasper T
GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
[TBL] [Abstract][Full Text] [Related]
4. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
5. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
James JS
AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151
[TBL] [Abstract][Full Text] [Related]
6. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S; Antunes OA; Fortunak JM
Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
[TBL] [Abstract][Full Text] [Related]
7. The (political) economics of antiretroviral treatment in developing countries.
Nattrass NJ
Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of the HIV/AIDS drug access initiatives in Côte d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa.
Katzenstein D; Laga M; Moatti JP
AIDS; 2003 Jul; 17 Suppl 3():S1-4. PubMed ID: 14565603
[No Abstract] [Full Text] [Related]
9. GATT and the gap: how to save lives.
James JS
AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
[TBL] [Abstract][Full Text] [Related]
10. Improving access to essential drugs for people living with HIV/AIDS.
Balasubramaniam K
Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
[No Abstract] [Full Text] [Related]
11. Learning and doing: operational research and access to HIV treatment in Africa.
Katzenstein D; Koulla-Shiro S; Laga M; Moatti JP
AIDS; 2010 Jan; 24 Suppl 1():S1-4. PubMed ID: 20023435
[No Abstract] [Full Text] [Related]
12. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11785481
[No Abstract] [Full Text] [Related]
13. Universal access to antiretroviral therapy: when, not if.
Carpenter CC
Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
[No Abstract] [Full Text] [Related]
14. Initiative to promote access to quality HIV medicines releases first batch of results today.
J Adv Nurs; 2002 Aug; 39(3):215. PubMed ID: 12174834
[No Abstract] [Full Text] [Related]
15. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11702763
[No Abstract] [Full Text] [Related]
16. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
17. Access to affordable drugs hinges on competition. Study notes lowest prices in India, South Africa.
AIDS Alert; 2004 Nov; 19(11):129-30. PubMed ID: 15562531
[TBL] [Abstract][Full Text] [Related]
18. Global good news: many more treated.
AIDS Treat News; 2005 Jan; (409):6-7. PubMed ID: 15791715
[TBL] [Abstract][Full Text] [Related]
19. European Parliament supports treatment access in developing countries.
James JS
AIDS Treat News; 2001 Mar; (363):4-5. PubMed ID: 11547677
[No Abstract] [Full Text] [Related]
20. A visit to India: drug prices, research, & global access.
Scondras D
AIDS Treat News; 1999 Jan; (No 311):6-8. PubMed ID: 11366155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
